A study of compressibility and compactibility of directly compressible tableting materials containing tramadol hydrochloride
positive properties of individual ingredients and suppressing the negative ones. They may also be of multifunctional character (3) . Dry binders include also substances considered in this study, i.e., Prosolv ® SMCC 90 and Disintequik ™ MCC 25. Prosolv ® SMCC is silicified microcrystalline cellulose (SMCC) containing 98 % of microcrystalline cellulose (MCC) and 2 % of colloidal silicon dioxide in a patented homogeneous mixture. It shows some advantages, such as good flow properties, a short period of disintegration, and high mechanical strength of tablets resulting from the intersurface interaction of silicon dioxide and MCC (4, 5) . In coprocessing, colloidal silicon dioxide is uniformly dispersed over microcrystalline cellulose and forms a rough surface of SMCC in comparison with MCC, the surface of which is much smoother and smaller (6) . Prosolv ® SMCC 90 contains particles of an average size of 110 μm, which ensures good flowability and also suitability for direct compression (7) . Disintequik™ MCC 25 is a relatively new coprocessed dry binder containing 75 % of α-lactose monohydrate and 25 % of microcrystalline cellulose (8) . This combination of substances is employed because of their synergic effect, which consists of greater strength and rapid disintegration of tablets. The lactose present is a fragile material, in which fragmentation takes place, thus providing areas for the development of new bonds. MCC is characterized by plastic deformation and enables rapid disintegration of tablets (9) . Disintequik™ MCC 25 is characterized by better flow properties, which support mass uniformity of tablets and better compressibility than in the physical mixture of lactose and microcrystalline cellulose (8) . Hydrophilic gel matrix tablets also contain an auxiliary gel-forming substance, which decelerates the release of the active ingredient. This excipient is very often hypromellose, which comes in several viscosity degrees (10) . Examples are the products of Methocel™ Premium K4M and K100M, which were employed in this study.
The aim of this paper was to study compressibility and compactibility of directly compressible tableting materials intended for preparation of hydrophilic gel matrix tablets with tramadol hydrochloride. Tableting materials tested included two types of coprocessed dry binders and two viscosity types of hypromellose in concentrations of 30 and 50 %. Compressibility was evaluated by means of the energy profile of the compression process and compactibility by the tensile strength of tablets.
EXPERIMENTAL

Materials
Silicified microcrystalline cellulose Prosolv ® SMCC 90 was supplied by JRS Pharma, GmbH+Co.kG (Germany), Disintequik ™ MCC 25 by Kerry (USA), hypromellose (Methocel ™ K4M Premium CR, Methocel ™ K100M Premium CR) by the firm Colorcon GmbH (Germany). Magnesium stearate was obtained from Acros Organics (USA). Tramadol hydrochloride was from Sigma-Aldrich (Czech Republic).
Preparation of tableting materials
Altogether sixteen tableting materials of the following compositions were prepared and tested (Table I) .
Tableting materials were prepared using a mixing cube KB 15S (Erweka GmbH, Germany). The mixing rate was 17 rot/min. The appropriate type of Methocel™ with Prosolv ® SMCC 90 or Disintequik™ MCC 25 was first mixed for a period of 5 minutes. Tramadol was then added for another 5 minutes, and finally magnesium stearate was added for a mixing period of 2.5 minutes. Mixtures without the active ingredient were prepared in the same manner without the mixing step with tramadol, their mass being 20 g. The mass of tableting materials with tramadol was 30 g.
Preparation of tablets and energy evaluation of compression process
Tablets were compressed using a material testing equipment T1-FRO 50 TH.A1K Zwick/Roell (Zwick GmbH & Co, Germany) by means of a special die with a lower and an upper punch. The rate of compaction was 40 mm min -1 , pre-load was 2 N, and the rate of preload was 2 mm s -1 . The tablets were of cylindrical shape without facets, with a 13 mm diameter, m = 0.5000 ± 0.0010 g. The employed compression force was 5 kN. At this compression force, 10 tablets were compressed. The computer program testXpert V 9.01 (Zwick GmbH&Co) simultaneously recorded the energy process of compression by means of the "force-displacement" record and numerically evaluated the energy balance of compression, i.e., the energy of precompression E 1 , energy of plastic deformation E 2 , and energy of elastic deformation E 3 , energy of compression E com , which is the sum of E 2 and E 3, total energy E max , which is the sum of all energies, and plasticity (11, 12) . 
Measurement of tablet tensile strength
Tensile strength of tablets was measured in 10 tablets no sooner than 24 hours after compression (tablets were stored in plastic tubes). Measurements were performed using a Schleuniger apparatus (Dr. Schleuniger Pharmatron AG, Switzerland), which measures the diameter and height of tablets with a precision of 0.01 mm and destruction force in N. Tensile strength of tablets was subsequently calculated according to the equation (Eq. 1) (13):
where P is tensile strength of tablets in MPa, F is destruction force in N, d is tablet diameter in mm, h is tablet height in mm.
Mathematical and statistical processing of results
The results of tensile strengths of tablets were statistically processed by means of the computer programs Excel and Qcexpert (TriloByte Statistical Software, s.r.o., Czech Republic). The energy and plasticity values were statistically processed by the computer program testXpert V 9.01 (Zwick GmbH&Co, Germany) directly during compaction. In the case of similar significance of values, an ANOVA test at a level of significance of 0.05 was employed.
RESULTS AND DISCUSSION
The aim of the paper is to evaluate the compressibility and compactibility of directly compressible tableting materials containing the active ingredient tramadol hydrochloride, two types of coprocessed dry binders and two types of hypromellose differing in the viscosity degree. The coprocessed dry binders employed were Prosolv ® SMCC 90, which is silicified microcrystalline cellulose with 2 % of colloidal magnesium dioxide, and Disintequik™ MCC 25, which contains 75 % of α-lactose monohydrate and 25 % of microcrystalline cellulose. In the function of hypromellose, i.e., the substance decelerating the release of the active ingredient, Methocel™ Premium K4M and Methocel™ Premium K100M in concentrations of 30 and 50 % were used. The lubricant employed in all tableting materials was magnesium stearate in a concentration of 1 %. Compressibility was evaluated by means of the energy profile of the compression process and compactibility by tensile strength of tablets. The compression force of 5 kN was selected in such a way as to maintain the strength of the compacts from the tableting materials with both coprocessed dry binders higher than the lower limit of the optimal tensile strength of tablets, which is 0.56 MPa (14) .
Energy profile of compression process
Values of the energy profile of the compression process at the compression force of 5 kN are shown in Tables II and III Values of the energy of precompression E 1 in the tableting materials without the active ingredient are higher and more equalized in the case of Prosolv SMCC 90. In the case of Disintequik MCC 25, the same influence is observed as in the E max values, which means higher values for a 50 % concentration of both types of Methocel and an insignificant difference within the type of Methocel used (30 % of Methocel p = 0.074; 50 % of Methocel p = 0.089). As far as the tableting materials with tramadol are concerned, the E 1 values in the tableting materials with Prosolv SMCC 90 are higher and more equalized than in the tableting materials with Disintequik MCC 25; tramadol decreases them slightly. In the case of tableting materials with Disintequik MCC 25, higher values are seen again in the case of a 50 % concentration of both Methocel types and the addition of tramadol slightly decreases them. Another parameter under evaluation was the energy of compression E com , which includes the energy accumulated in the tablet after compression, or the energy of plasticity (E 2 ) and also the energy released during the decompression, or the energy of 
Tensile strength of tablets
The tensile strength values of tablets are shown in Figs. 1-3 . Fig. 1 compares these values for all tableting materials without the active ingredient. The Figure shows 
7.24 ± 0.14 3.50 ± 0.13 3.14 ± 0.04 0. tion with the employed coprocessed dry binders is interesting. Thus, in the case of Prosolv SMCC 90, the tablets with a 30 % concentration of both types of Methocel are stronger, whereas in the case of Disintequik MCC 25, tablets with a 50 % concentration of both types of Methocel are stronger. The strength of tablets of all tableting materials with Prosolv SMCC 90 is represented in Fig. 2 . This figure shows a decrease in the strength of tablets due to the addition of tramadol, but also equalization of the strength of tablets for all compositions used (p = 0.252). In the case of the tableting materials with Disintequik MCC 25, there is also a decrease in the strength of tablets by the action of tramadol, tablets with 50 % of both types of Methocel remaining stronger (Fig. 3) .
CONCLUSIONS
Tableting materials with Proslov SMCC 90 were better compressible and showed better compaction and consolidation properties of particles than tableting materials with Disintequik MCC 25. The values of total energy of compression, plasticity and tensile strength of tablets were higher in the tableting materials with Prosolv SMCC 90. Tramadol decreased these values and in the tableting materials with Prosolv SMCC 90 it equalized the values of tablet strength for all compositions tested. Tablets were stronger with a higher viscosity degree of hypromellose, i.e., Methocel Premium K100M, in the case of both dry binders.
